查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930074

全球血型鑑定市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

Blood Group Typing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 177 Pages | 商品交期: 請詢問到貨日

價格

血型鑑定市場成長驅動因子

全球血型鑑定市場在現代醫學中發揮至關重要的作用，為輸血、器官移植、創傷救治和產前檢測提供支援。根據 Fortune Business Insights 預測，該市場預計在 2025 年達到 23.1 億美元，並從 2026 年的 25.2 億美元增長到 2034 年的 52.7 億美元，2026 年至 2034 年的複合年增長率 (CAGR) 為 9.60%。這一強勁的成長動能主要得益於全球捐血量的增加、創傷病例的增加以及移植手術的普及。

市場動態與流行病學因素

血型鑑定在急診和外科手術中至關重要，因為它能確定捐血者和受血者的血型是否相容。意外事故和創傷病例的增加顯著提高了對大量輸血的需求。研究表明，十分之六的創傷相關死亡發生在最初3小時內，原因是出血過多，凸顯了快速血型鑑定的重要性。

此外，世界衛生組織（WHO）報告稱，2008年至2018年間，自願捐血量增加了1070萬，直接促使血型鑑定數量的增加。慢性疾病負擔的加重、外科手術的增加以及產前篩檢計畫的擴展也進一步推動了市場擴張。

新冠疫情對市場的影響

由於捐血量減少、供應鏈中斷以及就診量下降，新冠疫情暫時擾亂了血型鑑定市場。 2020財年，包括Bio-Rad Laboratories在內的多家大型公司報告稱，其臨床診斷業務收入下降了7.6%。然而，在患者就診量改善和自動化血型鑑定技術加速普及的推動下，預計該市場將在2021年和2022年復甦，恢復成長動能。 主要市場趨勢 影響市場的關鍵趨勢是自動化血型鑑定技術的應用，包括基於PCR和微陣列的系統。這些技術提高了檢測準確性，減少了人為誤差，並緩解了熟練醫務人員短缺的問題。例如，2020年7月，日本東京理科大學的科學家開發出一種晶片實驗室設備，能夠在五分鐘內確定血型，並取得了技術突破。

市場區隔分析

依產品類型劃分，試劑和試劑盒將主導市場，到 2026 年將佔 80.43% 的市場佔有率，這主要得益於它們在輸血和捐血過程中的廣泛應用。隨著自動化技術的進步，儀器的市場佔有率預計將穩定成長。

依檢測類型劃分，抗體篩檢將在 2026 年佔市場主導地位，市佔率為 39.80%，這主要得益於產前檢測的興起和慢性病盛行率的上升。其次是 ABO 血型檢測，器官移植的增加推動了對 HLA 分型和交叉配對的需求。

依技術劃分，血清學檢測將在 2026 年佔最大市場佔有率，達到 59.42%，這主要得益於其操作簡便和廣泛應用。分子檢測由於能夠檢測弱抗原變異體並提高輸血安全性，預計將成長更快。

依最終用戶劃分，獨立實驗室和血庫將在2026年佔59.42%的市場佔有率，這主要得益於檢測網路的擴展，尤其是在新興經濟體。

區域洞察

北美地區憑藉強有力的報銷政策和對輸血的高需求，將以34.70%的市場佔有率引領全球市場，預計到2025年市場規模將達到8億美元。美國市場預計到2026年將達到8.1億美元。

歐洲則位居第二，主要得益於輸血量的成長和政府主導的器官捐贈計畫。

由於研發投入增加，亞太地區預計將實現強勁成長，其中中國、日本和印度預計到2026年將顯著擴張。

拉丁美洲以及中東和非洲是新興市場，這得益於醫療基礎設施的改善和捐血意識的提高。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 血型鑑定技術的最新進展
  • 主要國家的捐血量
  • 主要國家和地區的輸血量
  • 產業關鍵趨勢：併購、商業聯盟
  • HLA分型產品領域其他公司概覽
  • HLA分型價格分析產品
  • 新冠疫情對血型鑑定市場的影響

第五章：全球血型鑑定市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品分類
    • 儀器
    • 試劑和試劑盒
  • 市場分析、洞察與預測：依檢測類型
    • ABO血型檢測
    • 抗原分型
    • 抗體篩檢
    • 交叉配血試驗
    • HLA分型
  • 市場分析、洞察與預測：依技術分類
    • 血清學檢測
    • 分子檢測
  • 市場分析、洞察與預測：依最終用戶分類
    • 醫院實驗室
    • 獨立實驗室、血庫
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美血型鑑定市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲血型鑑定市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國王國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太地區血型鑑定市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲血型鑑定市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

章節10：中東與非洲血型鑑定市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC) 國家
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 世界市場佔有率分析(2025年)
  • 企業簡介
    • Quotient Limited
    • CareDx Inc.
    • Agena Bioscience, Inc.(Mesa Laboratories, Inc.)
    • DIAGAST
    • Illumina, Inc.
    • Grifols, S.A.
    • Immucor, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • QIAGEN
    • Beckman Coulter, Inc.(Danaher)
    • QuidelOrtho Corporation
Product Code: FBI101767

Growth Factors of blood group typing Market

The global blood group typing market plays a critical role in modern healthcare, supporting blood transfusions, organ transplantation, trauma care, and prenatal testing. According to Fortunebusinessinsights, the market was valued at USD 2.31 billion in 2025 and is projected to grow from USD 2.52 billion in 2026 to USD 5.27 billion by 2034, registering a CAGR of 9.60% during 2026-2034. The strong growth trajectory is driven by rising blood donations, increasing trauma cases, and expanding transplantation procedures worldwide.

Market Dynamics and Epidemiological Drivers

Blood group typing determines compatibility between donors and recipients, making it indispensable in emergency medicine and surgical care. The rising incidence of accidents and trauma cases has significantly increased the need for massive blood transfusions. Studies indicate that 6 out of 10 trauma-related deaths occur within the first three hours due to excessive bleeding, highlighting the critical role of timely blood typing.

Additionally, the World Health Organization (WHO) reported a rise of 10.7 million voluntary blood donations between 2008 and 2018, directly increasing the volume of blood group typing procedures. The growing burden of chronic diseases, rising surgical volumes, and expanding prenatal screening programs further support market expansion.

Market Impact of COVID-19

The COVID-19 pandemic temporarily disrupted the blood group typing market due to reduced blood donations, supply chain interruptions, and fewer hospital visits. In FY 2020, key players such as Bio-Rad Laboratories, Inc. reported a 7.6% decline in revenues from clinical diagnostics segments. However, market recovery was observed in 2021 and 2022, supported by improved patient inflow and accelerated adoption of automated blood typing technologies, restoring the market's growth momentum.

Key Market Trends

A major trend shaping the market is the adoption of automated blood group typing technologies, including PCR-based and microarray systems. These technologies improve testing accuracy, reduce human errors, and address shortages of skilled healthcare professionals. For example, in July 2020, scientists from Tokyo University of Science, Japan, developed a lab-on-a-chip device capable of determining blood type within five minutes, marking a significant technological advancement.

Market Segmentation Analysis

By Product, reagents and kits dominated the market, accounting for 80.43% share in 2026, due to their extensive use in transfusion and donation procedures. Instruments are expected to grow steadily with increased automation.

By Test Type, antibody screening led the market with a 39.80% share in 2026, driven by growing prenatal testing and chronic disease prevalence. ABO testing followed, while HLA typing and cross-matching tests are gaining traction due to rising organ transplantation procedures.

By Technique, serology tests held the largest share at 59.42% in 2026, owing to ease of use and widespread availability. Molecular tests are projected to grow faster due to their ability to detect weak antigen variants and improve transfusion safety.

By End User, independent laboratories and blood banks dominated with a 59.42% share in 2026, supported by expanding laboratory networks, particularly in emerging economies.

Regional Insights

North America dominated the global market with a 34.70% share in 2025, reaching USD 0.8 billion, driven by strong reimbursement policies and high transfusion demand. The U.S. market is projected to reach USD 0.81 billion by 2026.

Europe ranked second, supported by increasing transfusion volumes and government-led organ donation initiatives.

Asia Pacific is expected to witness strong growth due to rising R&D investments, with China, Japan, and India showing notable expansion by 2026.

Latin America and the Middle East & Africa are emerging markets, supported by improving healthcare infrastructure and growing awareness of blood donations.

Competitive Landscape

The market is semi-consolidated, led by QuidelOrtho Corporation, followed by Grifols S.A. and Bio-Rad Laboratories, Inc. These players focus on product innovation, strategic partnerships, and geographic expansion. Recent launches such as automated analyzers and next-generation HLA typing tests continue to strengthen competition.

Conclusion

In conclusion, the global blood group typing market is set for robust growth from USD 2.31 billion in 2025 to USD 5.27 billion by 2034, driven by increasing blood donations, trauma cases, and transplantation procedures. Technological advancements, especially in automated and molecular testing, are transforming diagnostic efficiency and safety. While infrastructure gaps in emerging countries remain a challenge, sustained government initiatives and private-sector innovation are expected to strengthen market penetration. Overall, the market presents strong long-term growth opportunities across both developed and developing regions.

Segmentation By Product

  • Instruments
  • Reagents & Kits

By Test Type

  • ABO Tests
  • Antigen Typing
  • Antibody Screening
  • Cross-matching Tests
  • HLA Typing

By Technique

  • Serology Tests
  • Molecular Tests

By End-user

  • Hospital-based Laboratories
  • Independent Laboratories & Blood Banks

By Region

  • North America (By Product, By Test Type, By Technique, By End-user, and By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, By Test Type, By Technique, By End-user, and By Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Blood Group Typing Techniques
  • 4.2. Number of Blood Donations, For Key Countries
  • 4.3. Number of Blood Transfusions, For Key Countries/ Region
  • 4.4. Key Industry Developments: Mergers, Partnership, Acquisitions
  • 4.5. Brief Overview of Other Companies Operating in HLA Typing Products
  • 4.6. Pricing Analysis of HLA Typing Products
  • 4.7. Impact of COVID-19 on Blood Group Typing Market

5. Global Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Kits
  • 5.2. Market Analysis, Insights and Forecast - By Test Type
    • 5.2.1. ABO Tests
    • 5.2.2. Antigen Typing
    • 5.2.3. Antibody Screening
    • 5.2.4. Cross-matching Tests
    • 5.2.5. HLA Typing
  • 5.3. Market Analysis, Insights and Forecast - By Techniques
    • 5.3.1. Serology Tests
    • 5.3.2. Molecular Tests
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospital-based Laboratories
    • 5.4.2. Independent Laboratories & Blood Banks
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Kits
  • 6.2. Market Analysis, Insights and Forecast - By Test Type
    • 6.2.1. ABO Tests
    • 6.2.2. Antigen Typing
    • 6.2.3. Antibody Screening
    • 6.2.4. Cross-matching Tests
    • 6.2.5. HLA Typing
  • 6.3. Market Analysis, Insights and Forecast - By Techniques
    • 6.3.1. Serology Tests
    • 6.3.2. Molecular Tests
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospital-based Laboratories
    • 6.4.2. Independent Laboratories & Blood Banks
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Kits
  • 7.2. Market Analysis, Insights and Forecast - By Test Type
    • 7.2.1. ABO Tests
    • 7.2.2. Antigen Typing
    • 7.2.3. Antibody Screening
    • 7.2.4. Cross-matching Tests
    • 7.2.5. HLA Typing
  • 7.3. Market Analysis, Insights and Forecast - By Techniques
    • 7.3.1. Serology Tests
    • 7.3.2. Molecular Tests
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospital-based Laboratories
    • 7.4.2. Independent Laboratories & Blood Banks
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Kits
  • 8.2. Market Analysis, Insights and Forecast - By Test Type
    • 8.2.1. ABO Tests
    • 8.2.2. Antigen Typing
    • 8.2.3. Antibody Screening
    • 8.2.4. Cross-matching Tests
    • 8.2.5. HLA Typing
  • 8.3. Market Analysis, Insights and Forecast - By Techniques
    • 8.3.1. Serology Tests
    • 8.3.2. Molecular Tests
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospital-based Laboratories
    • 8.4.2. Independent Laboratories & Blood Banks
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Kits
  • 9.2. Market Analysis, Insights and Forecast - By Test Type
    • 9.2.1. ABO Tests
    • 9.2.2. Antigen Typing
    • 9.2.3. Antibody Screening
    • 9.2.4. Cross-matching Tests
    • 9.2.5. HLA Typing
  • 9.3. Market Analysis, Insights and Forecast - By Techniques
    • 9.3.1. Serology Tests
    • 9.3.2. Molecular Tests
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospital-based Laboratories
    • 9.4.2. Independent Laboratories & Blood Banks
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Blood Group Typing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Kits
  • 10.2. Market Analysis, Insights and Forecast - By Test Type
    • 10.2.1. ABO Tests
    • 10.2.2. Antigen Typing
    • 10.2.3. Antibody Screening
    • 10.2.4. Cross-matching Tests
    • 10.2.5. HLA Typing
  • 10.3. Market Analysis, Insights and Forecast - By Techniques
    • 10.3.1. Serology Tests
    • 10.3.2. Molecular Tests
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospital-based Laboratories
    • 10.4.2. Independent Laboratories & Blood Banks
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Quotient Limited
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. CareDx Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Agena Bioscience, Inc. (Mesa Laboratories, Inc.)
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. DIAGAST
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Illumina, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Grifols, S.A.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Immucor, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Bio-Rad Laboratories, Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Thermo Fisher Scientific Inc.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Merck KGaA
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
    • 11.2.11. QIAGEN
      • 11.2.11.1. Overview
      • 11.2.11.2. Products & Services
      • 11.2.11.3. SWOT Analysis
      • 11.2.11.4. Recent Developments
      • 11.2.11.5. Strategies
      • 11.2.11.6. Financials (Based on Availability)
    • 11.2.12. Beckman Coulter, Inc. (Danaher)
      • 11.2.12.1. Overview
      • 11.2.12.2. Products & Services
      • 11.2.12.3. SWOT Analysis
      • 11.2.12.4. Recent Developments
      • 11.2.12.5. Strategies
      • 11.2.12.6. Financials (Based on Availability)
    • 11.2.13. QuidelOrtho Corporation
      • 11.2.13.1. Overview
      • 11.2.13.2. Products & Services
      • 11.2.13.3. SWOT Analysis
      • 11.2.13.4. Recent Developments
      • 11.2.13.5. Strategies
      • 11.2.13.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 02: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 03: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 04: Global Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 05: Global Blood Group Typing Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 06: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 07: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 08: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 09: North America Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 10: North America Blood Group Typing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 12: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 13: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 14: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 15: Europe Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 16: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 17: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 18: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 19: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 22: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 23: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 24: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 25: Latin America Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Product, 2021-2034
  • Table 27: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Test Type, 2021-2034
  • Table 28: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Techniques, 2021-2034
  • Table 29: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Middle East & Africa Blood Group Typing Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

List of Figures

  • Figure 01: Global Blood Group Typing Market Value Share (%), By Product, 2025 & 2034
  • Figure 02: Global Blood Group Typing Market Value Share (%), By Test Type, 2025 & 2034
  • Figure 03: Global Blood Group Typing Market Value Share (%), By Techniques, 2025 & 2034
  • Figure 04: Global Blood Group Typing Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Blood Group Typing Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 07: North America Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 08: North America Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 09: North America Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 10: North America Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 11: North America Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 12: North America Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 13: North America Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 14: North America Blood Group Typing Market Value (USD billion), By Country, 2025 & 2034
  • Figure 15: North America Blood Group Typing Market Value Share (%), By Country, 2025
  • Figure 16: Europe Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 17: Europe Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 18: Europe Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 19: Europe Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 20: Europe Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 21: Europe Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 22: Europe Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 23: Europe Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 24: Europe Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 25: Europe Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 26: Asia Pacific Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 27: Asia Pacific Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 28: Asia Pacific Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 29: Asia Pacific Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 30: Asia Pacific Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 31: Asia Pacific Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 32: Asia Pacific Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 33: Asia Pacific Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 34: Asia Pacific Blood Group Typing Market Value (USD billion), By Country/ Sub-Region, 2025 & 2034
  • Figure 35: Asia Pacific Blood Group Typing Market Value Share (%), By Country/ Sub-Region, 2025
  • Figure 36: Latin America Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 37: Latin America Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 38: Latin America Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 39: Latin America Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 40: Latin America Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 41: Latin America Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 42: Latin America Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 43: Latin America Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 44: Latin America Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 45: Latin America Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 46: Middle East & Africa Blood Group Typing Market Value (USD billion), By Product, 2025 & 2034
  • Figure 47: Middle East & Africa Blood Group Typing Market Value Share (%), By Product, 2025
  • Figure 48: Middle East & Africa Blood Group Typing Market Value (USD billion), By Test Type, 2025 & 2034
  • Figure 49: Middle East & Africa Blood Group Typing Market Value Share (%), By Test Type, 2025
  • Figure 50: Middle East & Africa Blood Group Typing Market Value (USD billion), By Techniques, 2025 & 2034
  • Figure 51: Middle East & Africa Blood Group Typing Market Value Share (%), By Techniques, 2025
  • Figure 52: Middle East & Africa Blood Group Typing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 53: Middle East & Africa Blood Group Typing Market Value Share (%), By End User, 2025
  • Figure 54: Middle East & Africa Blood Group Typing Market Value (USD billion), By Country/Sub-Region, 2025 & 2034
  • Figure 55: Middle East & Africa Blood Group Typing Market Value Share (%), By Country/Sub-Region, 2025
  • Figure 56: Global Blood Group Typing Market Share (%), By Company, 2025